ALNYLAM PHARMACEUTICALS INC ($ALNY)

3 tracked superinvestors hold ALNYLAM PHARMACEUTICALS INC (ALNY), worth $1.5B combined, led by Overdeck / Siegel. Smart money is accumulating ALNY as of the latest 13F filings.

Current price

$312.79

BiotechnologyNASDAQUS

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products…

Market cap

$39.5B

P/E

74.59

Div yield

0.0%

Revenue YoY

65.2%

Analyst target

$451

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

3

tracked 13F / N-PORT funds

Combined value

$1.5B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

+2

2 buying · 0 selling

Smart money is net accumulating ALNY: 2 funds added or opened versus 0 trimming.

The smart-money take on ALNY

ALNYLAM PHARMACEUTICALS INC (ALNY) appears mainly in diversified and quant books here (3 funds, $1.5B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The largest position belongs to Overdeck / Siegel at 0.6% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 2 added and 0 trimmed, a net add.

Superinvestors holding ALNY

InvestorMove% of their portfolioPosition value
2
Added0.6%$659M
3
Steve Wymer

Fidelity Growth Company

Held0.6%$433M
3
Brian Berghuis

T. Rowe Price Mid-Cap Growth

Added2%$386M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own ALNY?

3 tracked funds hold ALNYLAM PHARMACEUTICALS INC (ALNY), the largest being Overdeck / Siegel (Two Sigma) at 0.6% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling ALNY?

In the most recent 13F quarter, 2 tracked funds added or opened ALNY and 0 trimmed it.

How much ALNY do tracked funds hold?

Combined disclosed long exposure to ALNY across tracked superinvestors is $1.5B as of the Mar 2026 filings.

Stocks often held alongside ALNY

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.